EPCAM and urinary bladder carcinoma: These findings contradict the reported poor prognosis of breast, colorectal, pancreatic, ovarian and bladder cancers over-expressing EpCAM48–56, but is in line with the association of high levels of EpCAM with improved prognosis of colonic, gastric and renal cancer57–59.